For over thirty years (30) the firm of Jaroslawicz & Jaros has successfully brought many negligence cases involving serious personal injury suffered by persons which were caused by various Dangerous Drugs. The firm of Jaroslawicz & Jaros has litigated these cases at all levels of both the State and Federal courts for injuries caused by the negligence of the various drug companies as well as the doctors that prescribe them or fail to properly monitor their use.
In a case where a client of Jaroslawicz & Jaros was injured by a polio vaccine, lawyer David Jaroslawicz had the privilege to argue the appeal before the United States Court of Appeals for the Second Circuit. In Plummer v. Lederle Laboratories, Div. of American Cyanamid Co., Nos. 86-7768, 86-7798, United States Court of Appeals for the Second Circuit, 819 F.2d 349; CCH Prod. Liab. Rep. P11, 422, January 14, 1987, Argued, May 19, 1987, Decided. The issue was whether the drug company’s warnings regarding the polio vaccine were adequate and whether the company took reasonable efforts to distribute warnings to physicians. Click here for the details.
David Jaroslawicz was one of the plaintiff’s attorneys who successfully brought suit against Eli Lilly in a case that was heard by the New York Court of Appeals and established the right of DES victims to bring suit many years after the injury had occurred and there was difficulty identifying the defendant. David Jaroslawicz of Jaroslawicz & Jaros was responsible for the leading case of Bichler v. Eli Lilly & Co., Supreme Court of New York, Appellate Division, First Department, 79 A.D.2d 317; 436 N.Y.S.2d 625; February 24, 1981. This important case established a new and novel theory of liability that was upheld by the higher court where the court affirmed verdicts finding defendant liable under concerted action theory despite finding that plaintiff failed to prove defendant manufactured drug that caused plaintiff’s cancer as verdicts were supported by evidence.
Jaroslawicz & Jaros is now accepting Fosamax & Levaquin cases.
Jaroslawicz & Jaros was one of the first law firms to bring personal injury lawsuits involving persons who suffered from femur (thigh bone) low impact fractures as a result of taking Fosamax. Although other law firms have brought lawsuits against Merck, the manufacturer of Fosamax, at Jaroslawicz & Jaros we have brought suits as against the doctors who prescribed and then failed to monitor the effects of the drug until it was too late. While we have found that many women have made complaints of thigh pain to their various doctors while on Fosamax these complaints unfortunately have often not been properly followed up and investigated by their doctors. With proper treatment after complaints of thigh pain are made the doctors should have discontinued Fosamax, so that the bone could then heal, as studies have shown it does, and also have taken x-rays of the thigh bones to see if they were deteriorating.
Fosamax was at first marketed for the treatment of osteoporosis, defined as the thinning of bone tissue and loss of bone density over time. However more recently Fosamax is often prescribed for osteopenia, which is a condition where the bone mineral density is lower than normal, which is considered by many doctors to be a precursor to osteoporosis, However, not every person diagnosed with osteopenia will go on to develop osteoporosis and whether all women even with osteopenia require the use of Fosamax can also be debated. Some articles have taken the position that the manufacturer of Fosamax, Merck, has simply sought to expand the market for Fosamax by manufacturing and selling the machine that is used to diagnose osteopenia and then having the doctors prescribe Fosamax to treat it.
Unfortunately, we have found that many complaints that were made by women taking Fosamax have been ignored by their treating doctors, they then remain on Fosamax and ultimately the femur suddenly fractures “for no apparent reason”. We have seen this occur with one femur as well as with both femurs. For more information on Fosamax please go to our Home page and see the Article “Femur (Thigh) Fractures and Fosamax” written by Abraham Jaros & Theodore Rothman.
NYC accident law firm Jaroslawicz & Jaros has been successful in settling a case for a woman who suffered from a femur (thigh bone) low impact fracture after taking Fosamax while she was simply walking on the street and who was then sent to physical therapy while being treated at the hospital when she then fractured the other femur.
Levaquin is an antibiotic that is used to treat bacterial infections, including skin, sinus, urinary, respiratory and kidney among others. Levaquin is manufactured by Ortho-McNeil Pharmaceuticals and is available only by prescription. The use of Levaquin has been linked to tendon damage and ruptures, Achilles tendon rupture, Achilles tendonitis, injury to the shoulder rotator cuff as well as the hand, thumb and biceps among other injuries.
Since the damages suffered from an injured tendon or some of the other side effects from taking Levaquin have serious consequences you may have a medical malpractice case against your doctor or a product liability case against the manufacturer of the antibiotic.
If you or a loved one has suffered a fracture while taking Fosamax or tendon damage or rupture or other injuries while taking Levaquin or suffered any other injury as a result of taking any drug and are in need of legal assistance, call Jaroslawicz & Jaros at 212-227-2780, or toll free in New York 1-800-269-2780, or submit an online questionnaire. The initial consultation is free of charge, and if we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call to ensure that you do not waive your right to possible compensation.
